These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 6712730)
21. Differential inhibitory effect of long-chain acyl-CoA esters on succinate and glutamate transport into rat liver mitochondria and its possible implications for long-chain fatty acid oxidation defects. Ventura FV; Ruiter J; Ijlst L; de Almeida IT; Wanders RJ Mol Genet Metab; 2005 Nov; 86(3):344-52. PubMed ID: 16176879 [TBL] [Abstract][Full Text] [Related]
22. Prevention of 4-pentenoic acid-induced liver injury in rats by 16,16-dimethyl PGE2. Hidaka T; Inokuchi T; Nakamura Y; Kotegawa M; Sugiyama M; Ogura R Exp Mol Pathol; 1991 Oct; 55(2):135-42. PubMed ID: 1936211 [TBL] [Abstract][Full Text] [Related]
23. Alkylthio acetic acids (3-thia fatty acids)--a new group of non-beta-oxidizable peroxisome-inducing fatty acid analogues--II. Dose-response studies on hepatic peroxisomal- and mitochondrial changes and long-chain fatty acid metabolizing enzymes in rats. Berge RK; Aarsland A; Kryvi H; Bremer J; Aarsaether N Biochem Pharmacol; 1989 Nov; 38(22):3969-79. PubMed ID: 2574577 [TBL] [Abstract][Full Text] [Related]
24. Spiropentaneacetic acid as a specific inhibitor of medium-chain acyl-CoA dehydrogenase. Tserng KY; Jin SJ; Hoppel CL Biochemistry; 1991 Nov; 30(44):10755-60. PubMed ID: 1931995 [TBL] [Abstract][Full Text] [Related]
25. Effect of fatty acids and their derivatives on mitochondrial structures. Singh AK; Yoshida Y; Garvin AJ; Singh I J Exp Pathol; 1989; 4(1):9-15. PubMed ID: 2778551 [TBL] [Abstract][Full Text] [Related]
26. Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status. Tang W; Borel AG; Fujimiya T; Abbott FS Chem Res Toxicol; 1995; 8(5):671-82. PubMed ID: 7548749 [TBL] [Abstract][Full Text] [Related]
29. Altered hepatic mitochondrial fatty acid oxidation and ketogenesis in endotoxic rats. Takeyama N; Itoh Y; Kitazawa Y; Tanaka T Am J Physiol; 1990 Oct; 259(4 Pt 1):E498-505. PubMed ID: 2221051 [TBL] [Abstract][Full Text] [Related]
30. Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes. Osterloh J; Cunningham W; Dixon A; Combest D Med Toxicol Adverse Drug Exp; 1989; 4(4):272-94. PubMed ID: 2671597 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of hepatic fatty acid oxidation by bezafibrate and bezafibroyl CoA. Eacho PI; Foxworthy PS Biochem Biophys Res Commun; 1988 Dec; 157(3):1148-53. PubMed ID: 3264699 [TBL] [Abstract][Full Text] [Related]
32. Effects of thia-substituted fatty acids on mitochondrial and peroxisomal beta-oxidation. Studies in vivo and in vitro. Hovik R; Osmundsen H; Berge R; Aarsland A; Bergseth S; Bremer J Biochem J; 1990 Aug; 270(1):167-73. PubMed ID: 2396976 [TBL] [Abstract][Full Text] [Related]
33. Production of the features of Reye's syndrome in rats with 4-pentenoic acid. Glasgow AM; Chase HP Pediatr Res; 1975 Mar; 9(3):133-8. PubMed ID: 1121419 [TBL] [Abstract][Full Text] [Related]
34. Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial beta-oxidation of omega-phenyl fatty acids in rat liver. Yamada J; Ogawa S; Horie S; Watanabe T; Suga T Biochim Biophys Acta; 1987 Sep; 921(2):292-301. PubMed ID: 3651489 [TBL] [Abstract][Full Text] [Related]
35. Decreased mitochondrial oxidation of fatty acids in pregnant mice: possible relevance to development of acute fatty liver of pregnancy. Grimbert S; Fromenty B; Fisch C; Letteron P; Berson A; Durand-Schneider AM; Feldmann G; Pessayre D Hepatology; 1993 Apr; 17(4):628-37. PubMed ID: 8477967 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone. Foxworthy PS; Eacho PI Biochem J; 1988 Jun; 252(2):409-14. PubMed ID: 3415664 [TBL] [Abstract][Full Text] [Related]
38. [Study of the effect of an inhibitor of carnitine-dependent metabolism of mildronate on the oxidation of fatty acids in the liver mitochondria of intact rats]. Kagan TI; Simkhovich BZ; Kalvinysh IIa; Lukevits EIa Vopr Med Khim; 1991; 37(2):44-6. PubMed ID: 1897193 [TBL] [Abstract][Full Text] [Related]
39. 4-Bromo-2-octenoic acid specifically inactivates 3-ketoacyl-CoA thiolase and thereby fatty acid oxidation in rat liver mitochondria. Li JX; Schulz H Biochemistry; 1988 Aug; 27(16):5995-6000. PubMed ID: 3191104 [TBL] [Abstract][Full Text] [Related]
40. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Stanley CA; Hale DE; Coates PM; Hall CL; Corkey BE; Yang W; Kelley RI; Gonzales EL; Williamson JR; Baker L Pediatr Res; 1983 Nov; 17(11):877-84. PubMed ID: 6646897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]